Otsuka America Pharmaceutical, Inc. has developed an easy-to-use Hyponatremia Registry Study Results Interactive Tool to help you understand how the subjects in the Global Hyponatremia Registry Study (Registry) responded to fluid restriction. Response in the context of the Registry is defined by an increase in a study subjects serum sodium by at least 2 or 3 or 4 mEq/L over a 24hour period. Input a hypothetical patients characteristics and laboratory values, and choose from selected clinical considerations to see how similarly situated study subjects responded to fluid restriction.This tool has not been evaluated by the U.S. Food and Drug Administration. It is not intended to diagnose, treat, cure, or prevent any medical condition, disease, or health problem. Users of the application should not rely on information provided by the applicationincluding the datato diagnose or treat any medical condition, disease, or health problem.